<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Clin Cancer Res</journal-id>
        <journal-id journal-id-type="iso-abbrev">Clin Cancer Res</journal-id>
        <journal-id journal-id-type="pmc-domain-id">319</journal-id>
        <journal-id journal-id-type="pmc-domain">nihpa</journal-id>
        <journal-title-group>
          <journal-title>Clinical cancer research : an official journal of the American Association for Cancer Research</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">1078-0432</issn>
        <issn pub-type="epub">1557-3265</issn>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-is-collection-domain</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-collection-title</meta-name>
            <meta-value>NIHPA Author Manuscripts</meta-value>
          </custom-meta>
        </custom-meta-group>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC9438279</article-id>
        <article-id pub-id-type="pmcid-ver">PMC9438279.1</article-id>
        <article-id pub-id-type="pmcaid">9438279</article-id>
        <article-id pub-id-type="pmcaiid">9438279</article-id>
        <article-id pub-id-type="manuscript-id">NIHMS1816186</article-id>
        <article-id pub-id-type="pmid">35670774</article-id>
        <article-id pub-id-type="doi">10.1158/1078-0432.CCR-21-4272</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHMS1816186</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHPA1816186</article-id>
        <article-version article-version-type="pmc-version">1</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Article</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Chakraborty</surname>
              <given-names initials="G">Goutam</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="FN2" ref-type="author-notes">*</xref>
            <xref rid="FN3" ref-type="author-notes">#</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Nandakumar</surname>
              <given-names initials="S">Subhiksha</given-names>
            </name>
            <xref rid="A3" ref-type="aff">3</xref>
            <xref rid="A4" ref-type="aff">4</xref>
            <xref rid="FN2" ref-type="author-notes">*</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Hirani</surname>
              <given-names initials="R">Rahim</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="FN1" ref-type="author-notes">δ</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Nguyen</surname>
              <given-names initials="B">Bastien</given-names>
            </name>
            <xref rid="A3" ref-type="aff">3</xref>
            <xref rid="A4" ref-type="aff">4</xref>
            <xref rid="FN1" ref-type="author-notes">δ</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Stopsack</surname>
              <given-names initials="KH">Konrad H.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Kreitzer</surname>
              <given-names initials="C">Christoph</given-names>
            </name>
            <xref rid="A3" ref-type="aff">3</xref>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Rajanala</surname>
              <given-names initials="SH">Sai Harisha</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ghale</surname>
              <given-names initials="R">Romina</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Mazzu</surname>
              <given-names initials="YZ">Ying Z.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Pillarsetty</surname>
              <given-names initials="NVK">Naga Vara Kishore</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Mary Lee</surname>
              <given-names initials="GS">Gwo-Shu</given-names>
            </name>
            <xref rid="A6" ref-type="aff">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Scher</surname>
              <given-names initials="HI">Howard I.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A10" ref-type="aff">10</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Morris</surname>
              <given-names initials="MJ">Michael J.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Traina</surname>
              <given-names initials="T">Tiffany</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Razavi</surname>
              <given-names initials="P">Pedram</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Abida</surname>
              <given-names initials="W">Wassim</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Durack</surname>
              <given-names initials="JC">Jeremy C.</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Solomon</surname>
              <given-names initials="SB">Stephen B.</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Vander Heiden</surname>
              <given-names initials="MG">Matthew G.</given-names>
            </name>
            <xref rid="A7" ref-type="aff">7</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Mucci</surname>
              <given-names initials="LA">Lorelei A.</given-names>
            </name>
            <xref rid="A8" ref-type="aff">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Wibmer</surname>
              <given-names initials="AG">Andreas G.</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Schultz</surname>
              <given-names initials="N">Nikolaus</given-names>
            </name>
            <xref rid="A3" ref-type="aff">3</xref>
            <xref rid="A4" ref-type="aff">4</xref>
            <xref rid="A9" ref-type="aff">9</xref>
            <xref rid="FN3" ref-type="author-notes">#</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Kantoff</surname>
              <given-names initials="PW">Philip W.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="FN3" ref-type="author-notes">#</xref>
          </contrib>
        </contrib-group>
        <aff id="A1"><label>1.</label>Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY</aff>
        <aff id="A2"><label>2.</label>Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY</aff>
        <aff id="A3"><label>3.</label>Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY</aff>
        <aff id="A4"><label>4.</label>Human Oncology &amp; Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY</aff>
        <aff id="A5"><label>5.</label>Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY</aff>
        <aff id="A6"><label>6.</label>Department of Medicine, Dana-Farber Cancer Institute, Boston, MA</aff>
        <aff id="A7"><label>7.</label>Koch Institute for Integrative Cancer Research and the Department of Biology at Massachusetts Institute of Technology, Cambridge, MA</aff>
        <aff id="A8"><label>8.</label>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA</aff>
        <aff id="A9"><label>9.</label>Department of Epidemiology &amp; Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY</aff>
        <aff id="A10"><label>10.</label>Biomarker Development Program, Memorial Sloan Kettering Cancer Center, New York, NY</aff>
        <author-notes>
          <fn fn-type="equal" id="FN1">
            <label>δ</label>
            <p id="P1">Contributed equally</p>
          </fn>
          <fn fn-type="other" id="FN2">
            <label>*</label>
            <p id="P2">Co-first authors.</p>
          </fn>
          <fn fn-type="other" id="FN3">
            <label>#</label>
            <p id="P3">Co-corresponding Authors</p>
          </fn>
          <fn fn-type="con" id="FN4">
            <p id="P4">Author contributions:</p>
            <p id="P5">Conception and design: G Chakraborty, S Nandakumar, N Schultz, PW Kantoff</p>
            <p id="P6">Development of methodology: G Chakraborty, S Nandakumar, B Nguyen, KH Stopsack, C Kreitzer, P Razavi, GM Lee, AG Wibmer.</p>
            <p id="P7">Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): G Chakraborty, R Hirani, SH Rajanala, R Ghale, YZ Mazzu, JC Durack, S Solomon, AG Wibmer.</p>
            <p id="P8">Analysis and interpretation of data (eg, statistical analysis, biostatistics, computational analysis): S Nandakumar, B Nguyen, KH Stopsack, C Kreitzer, NVK Pillarsetty, HI Scher, M Morris, T Traina, P Razavi, W Abida, JC Durack, SB Solomon, MG Vander Heiden, LA Mucci, AG Wibmer, N Schultz, PW Kantoff</p>
            <p id="P9">Writing—original draft: G Chakraborty, S Nandakumar, B Nguyen, PW Kantoff</p>
            <p id="P10">Administrative, technical, or material support (ie, reporting or organizing data, constructing databases): G Chakraborty, S Nandakumar, B Nguyen, KH Stopsack.</p>
            <p id="P11">Study supervision: G Chakraborty, N Schultz, PW Kantoff.</p>
            <p id="P12">Final approval of the manuscript version submitted for publication: all authors.</p>
          </fn>
          <corresp id="CR1"><bold>Corresponding authors:</bold> Philip W. Kantoff, Nikolaus Schultz or Goutam Chakraborty, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA, <email>kantoffp@outlook.com</email>, Phone: 617-680-4850, <email>schultzn@mskcc.org</email>, <email>goutam.chakraborty@mountsinai.org</email></corresp>
        </author-notes>
        <pub-date pub-type="ppub">
          <day>15</day>
          <month>8</month>
          <year>2022</year>
        </pub-date>
        <volume>28</volume>
        <issue>16</issue>
        <issue-id pub-id-type="pmc-issue-id">416030</issue-id>
        <fpage>3603</fpage>
        <lpage>3617</lpage>
        <pub-history>
          <event event-type="nihms-submitted">
            <date>
              <day>27</day>
              <month>08</month>
              <year>2022</year>
            </date>
          </event>
          <event event-type="pmc-release">
            <date>
              <day>15</day>
              <month>02</month>
              <year>2023</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>15</day>
              <month>02</month>
              <year>2023</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2024-06-13 15:25:14.113">
              <day>13</day>
              <month>06</month>
              <year>2024</year>
            </date>
          </event>
        </pub-history>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1816186.pdf"/>
        <abstract id="ABS1">
          <sec id="S1">
            <title>Purpose:</title>
            <p id="P13">Oncogenic alterations of the phosphatidylinositol-3-kinase (PI3K)/AKT pathway occur in &gt;40% of patients with metastatic castration-resistant prostate cancer (mCRPC), predominantly via <italic toggle="yes">PTEN</italic> loss. The significance of other PI3K pathway components in prostate cancer is largely unknown.</p>
          </sec>
          <sec id="S2">
            <title>Experimental Design:</title>
            <p id="P14">Patients in this study underwent tumor sequencing using the MSK-IMPACT clinical assay to capture single-nucleotide variants, insertions, and deletions, copy number alterations, and structural rearrangements, or were profiled through The Cancer Genome Atlas. The association between <italic toggle="yes">PIK3R1</italic> alteration/expression and survival was evaluated using univariable and multivariable Cox proportional-hazards regression models. We used siRNA-based knockdown of <italic toggle="yes">PIK3R1</italic> for functional studies. FDG-PET/CT examinations were performed with a hybrid PET/CT scanner for some prostate cancer patients in MSK-IMPACT cohort.</p>
          </sec>
          <sec id="S3">
            <title>Results:</title>
            <p id="P15">Analyzing 1417 human prostate cancers, we found a significant enrichment of <italic toggle="yes">PIK3R1</italic> alterations in metastatic cancers compared to primary cancers. <italic toggle="yes">PIK3R1</italic> alterations or reduced mRNA expression tended to be associated with worse clinical outcomes in prostate cancer, particularly in primary disease, as well as in breast, gastric, and several other cancers. In prostate cancer cell lines, <italic toggle="yes">PIK3R1</italic> knockdown resulted in increased cell proliferation and AKT activity, including insulin-stimulated AKT activity. In cell lines and organoids, <italic toggle="yes">PIK3R1</italic> loss/mutation was associated with increased sensitivity to AKT inhibitors. <italic toggle="yes">PIK3R1</italic>-altered patient prostate tumors had increased uptake of the glucose analogue 18F-fluorodeoxyglucose in PET imaging, suggesting increased glycolysis.</p>
          </sec>
          <sec id="S4">
            <title>Conclusions:</title>
            <p id="P16">Our findings describe a novel genomic feature in metastatic prostate cancer and suggest that <italic toggle="yes">PIK3R1</italic> alteration may be a key event for insulin-PI3K-glycolytic pathway regulation in prostate cancer.</p>
          </sec>
        </abstract>
        <kwd-group>
          <kwd>Metastatic castration-resistant prostate cancer</kwd>
          <kwd>phosphatidylinositol-3-kinase pathway</kwd>
          <kwd>PIK3R1 alteration</kwd>
          <kwd>Akt inhibitor</kwd>
          <kwd>FDG-PET</kwd>
        </kwd-group>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
  </article>
</pmc-articleset>
